EverVet aligns with Freeman Spogli

Veterinary service platform, EverVet Partners, has partnered with private equity investor, Freeman Spogli & Co. With the investment backing, EverVet will be able to grow at a faster pace. 

The funding will increase the ability to grow with strategic partnerships with veterinarians, will increase the ability to recruit veterinarians, enhance technology, and increase operational efforts. 

“We are excited to partner with Freeman Spogli as EverVet continues building a veterinarian and customer-focused organization,” said Joe Luceri, co-founder and chief executive officer of EverVet.  “We chose Freeman Spogli as our new partner given our cultural alignment, their extensive experience successfully building consumer services and consumer healthcare brands, and experience scaling businesses organically and through M&A.”

EverVet was found in 2020 and now has expanded to operate 21 clinics in markets in different regions of the United States. Through the partnership, EverVet’s co-founder and CEO, co-founder and chief development officer, and the management team with continue to be shareholders and manage the company each day.  

"Through partnering with Freeman Spogli and continuing our partnership with Tailwind, EverVet will continue to invest in its corporate infrastructure to support growth and to partner with veterinarians through additional acquisitions,” said Len Podolsky, co-founder and chief development officer of EverVet. “Tailwind has been instrumental in establishing EverVet's foundation, and we are extremely excited to have great partners and a strong capital base as we continue EverVet's growth."

  • Please enter a comment

Name *
Email address *
Comment *

* Required fields

Information on the processing of your personal data
We inform you that, in compliance with the provisions of current national and European regulations for the Protection of Personal Data and Services of the Information Society and Electronic Commerce, by sending us this form you are expressly giving your consent to Grupo Asís Biomedia , SL, (hereinafter, "ASIS GROUP") so that, as the person in charge, it may process your personal data in order to respond to your request for contact and information by electronic means.

Likewise, when you expressly consent, we will process your personal data to send you specialized information, newsletters, offers and exclusive promotions from GRUPO ASIS and related companies.

For the aforementioned purpose, GRUPO ASIS may transfer your data to other companies linked to GRUPO ASIS or to third party service providers for the management of electronic communications and other security services, even in cases where they are outside of the European Union, provided that they legally guarantee the adequate level of protection required by European regulations.

At any time you can withdraw the consent given and exercise the rights of access, rectification, deletion, portability of your data and limitation or opposition to its treatment by contacting GRUPO ASIS by sending an email to protecciondatos @, or by written communication to address at Centro Empresarial El Trovador, 8th floor, office I, Plaza Antonio Beltrán Martínez 1, 50002, Zaragoza (Spain), indicating in either case the Ref. Personal data and the right you exercise, as well as attaching a copy of your ID or replacement identification document.

I have read and accept the treatment of my data according to the informed purpose and according Legal notes and the Privacy Policy
I wish to receive commercial information from GRUPO ASIS and related companies

More news

Cases of Crimean-Congo haemorrhagic fever cases linked to tick bites reported in Europe


Outcome of surgical correction of medial patellar luxation in dogs weighing less than 10 kg


A retrospective study of the efficacy of zonisamide in controlling seizures in cats


Cystostomy technique for management of obstructive urolithiasis in small ruminants


Factors associated with thrombotic disease in dogs with renal proteinuria




News of interest


Copyright © 2024 - All Rights Reserved
ISSN 2768-198X